In this episode, guest host Scott Adams has a conversation about the new reimbursement schedule from Medicare known as PAMA.
Scott first talks with Mark Zacur, VP & General Manager at Thermo Fisher Scientific where they talk about possible impacts on our healthcare system and patients.
Then Scott talks to Jim Poggi from Tested Insights on how this will impact the POL, or Physician Office Labs.
Note from Mark Zacur: “Views expressed through this podcast are my own and do not represent the opinions of any entity whatsoever with which I have been, am now, or will be affiliated with”
